NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Gross Block History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Gross Block | ₹256 Cr | ₹217 Cr | ₹148 Cr | ₹139 Cr | ₹130 Cr |
What is the latest Gross Block ratio of NGL FINECHEM ?
| Year | Gross Block |
|---|---|
| Mar2026 | ₹256 Cr |
| Mar2025 | ₹217 Cr |
| Mar2024 | ₹148 Cr |
| Mar2023 | ₹139 Cr |
| Mar2022 | ₹130 Cr |
How is Gross Block of NGL FINECHEM Trending?
| Years | Gross Block | % Change | |
|---|---|---|---|
| Mar2026 | ₹256 Cr | 17.80 | |
| Mar2025 | ₹217 Cr | 46.53 | |
| Mar2024 | ₹148 Cr | 6.26 | |
| Mar2023 | ₹139 Cr | 7.61 | |
| Mar2022 | ₹130 Cr | - | |
Compare Gross Block of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,743.1 Cr | -1.8% | -14.1% | 103.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -1.8% |
-14.1% |
103.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses